6-03-2023, 19:08

The Joint Corp. to Participate in the 35th Annual Roth

SCOTTSDALE, Ariz., March 06, 2023 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and
Globe Newswire6-03-2023, 19:08
6-03-2023, 18:39

Kineta to Host Key Opinion Leader Event on KVA12123: VISTA

SEATTLE, March 06, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused
Globe Newswire6-03-2023, 18:39
6-03-2023, 17:06

LIZHI INC. to Report Fourth Quarter and Fiscal Year 2022

Earnings Call Scheduled for 7:00 a.m. ET on March 16, 2023...
Globe Newswire6-03-2023, 17:06
6-03-2023, 16:36

Himax Technologies, Inc. to Attend 26th Credit Suisse Asian

TAINAN, Taiwan, March 06, 2023 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a
Globe Newswire6-03-2023, 16:36
6-03-2023, 02:01

Additional Data on Lumos OraGrowtH Trials Presented

Oral Presentation Highlighting Data on 15 Subjects from OraGrowtH212 Trial Supportive of Conclusions from Interim Data
Globe Newswire6-03-2023, 02:01
5-03-2023, 18:58

GDS to Report Fourth Quarter and Full Year 2022 Financial

SHANGHAI, China, March 05, 2023 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”)
Globe Newswire5-03-2023, 18:58
5-03-2023, 01:31

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE

– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic
Globe Newswire5-03-2023, 01:31
4-03-2023, 22:07

Cytokinetics Presents Positive Results From Cohort 4 of

Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in
Globe Newswire4-03-2023, 22:07
4-03-2023, 05:03

The RealReal Announces Inducement Grants under Nasdaq

SAN FRANCISCO, March 03, 2023 (GLOBE NEWSWIRE) -- The RealReal, Inc. (NASDAQ: REAL) – the world’s largest online
Globe Newswire4-03-2023, 05:03
4-03-2023, 04:15

Praxis Precision Medicines to Present at Upcoming Investor

BOSTON, March 03, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage
Globe Newswire4-03-2023, 04:15
4-03-2023, 04:03

Impel Pharmaceuticals to Participate in Upcoming Investor

SEATTLE, March 03, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage
Globe Newswire4-03-2023, 04:03
4-03-2023, 02:48

Cumulus Media’s Westwood One Presents Audio Coverage of

Coverage Includes 23 Games between Saturday, March 4th and Sunday, March 12th, 2023...
Globe Newswire4-03-2023, 02:48